Drug Discovery

With new drugs showing promise for Alzheimer’s, is the drug development drought over?

Sitting Down With… Sharon L Rogers, AmyriAD CEO, Renowned drug developer, 2023 Power Lister, and Olympic figure skating official

Why one company is focusing on camelid-derived antibodies to tackle dengue.

Studying the link between Alzheimer’s risk, estrogen levels, and menopausal status in women

Perrigo’s Opill receives FDA approval following unanimous support from advisory committees

How scientists extracted a treatment for episodic ataxia from traditional Kwakwaka'wakw medicine

Researchers demonstrate that microRNA-132 can significantly affect different brain cells, with potential implications for Alzheimer’s disease.

TUM Researchers create organoid that emulates the development of the human heart

Sitting Down With … Tirtha Chakraborty, Chief Scientific Officer at Vor Bio

Researchers identify brain pathway – miR483-5p/Pgap2 – that holds promise for future anxiety treatments